Open access · US-GOV
via ClinicalTrials.gov Clinical trial
A Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Effects and Impacts of Supplemental Pentadecanoic Acid on Red Blood Cell Health and Activity and Predicted Biological Age in Healthy Older Adults
Authors not listed
ReCellience15, Inc · 2027
Abstract
This Phase II randomized, double-blind, placebo-controlled, parallel-group study will evaluate the effects of pentadecanoic acid (C15:0) supplementation on red blood cell (RBC) health and predicted biological age in healthy adults aged 55 years and older. A total of 93 participants will be randomized to receive 200 mg of C15:0, 300 mg of C15:0, or placebo daily for approximately 12 weeks. The primary objective is to assess the effect of C15:0 on red blood cell distribution width (RDW-CV), a marker of RBC health, compared with placebo. Secondary outcomes include measures of inflammation, hematologic and iron metabolism markers, circulating C15:0 levels, biological age-related biomarkers, sleep quality, fatigue, energy, and health-related quality of life. Safety and tolerability will also be evaluated throughout the study.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-10-29 MST
Cite this
APA
Anonymous. (2027). A Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Effects and Impacts of Supplemental Pentadecanoic Acid on Red Blood Cell Health and Activity and Predicted Biological Age in Healthy Older Adults. <em>ReCellience15, Inc</em>. https://clinicaltrials.gov/study/NCT07812792
Vancouver
Anonymous. A Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Effects and Impacts of Supplemental Pentadecanoic Acid on Red Blood Cell Health and Activity and Predicted Biological Age in Healthy Older Adults. ReCellience15, Inc. 2027.
BibTeX
@misc{anon2027ARando,
title = {A Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Effects and Impacts of Supplemental Pentadecanoic Acid on Red Blood Cell Health and Activity and Predicted Biological Age in Healthy Older Adults},
author = {Anonymous},
journal = {ReCellience15, Inc},
year = {2027},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Epirium Bio Inc. 2027
Open access · US-GOV
A Phase 2b, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of MF-300 in Subjects With Age-related Sarcopenia
EUROPEAN LIFE SCIENCE RESEARCH ASSOCIATION 2026
Open access · US-GOV
A Randomized, Double-Blind, Placebo-Controlled Trial Evaluating the Effects of NVTIA® Ergothioneine Supplementation on Healthy Aging Biomarkers and Skin Health in Healthy Adults
Liaquat University of Medical & Health Sciences 2026
Open access · US-GOV
Effects of Ursolic Acid-Standardized Apple Pomace Extract Formulated With Phospholipids on Muscle Strength and Physical Performance in Older Adults With Mild Sarcopenia: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial
BMC Nutrition 2020
Open access · CC-BY
Associations of time-restricted eating with health-related quality of life and sleep in adults: a secondary analysis of two pre-post pilot studies
Capital University of Physical Education and Sports, China 2025
Open access · US-GOV
Effect of Resistance-Led Multicomponent Training Combined With Nutritional Supplementation on Intrinsic Capacity and Disability Risk in Chinese Rural Older Adults
Cognition Therapeutics 2023
Open access · US-GOV